Re: “Diagnostic Performance of Technetium-99m Methoxy-Isobutyl-Isonitrile for Differentiation of Malignant Thyroid Nodules: A Systematic Review and Meta-Analysis” by Kim et al . ( Thyroid 2018;28:1339–1348)
Restricted accessLetterFirst published online June, 2019
Re: “Diagnostic Performance of Technetium-99m Methoxy-Isobutyl-Isonitrile for Differentiation of Malignant Thyroid Nodules: A Systematic Review and Meta-Analysis” by Kim et al . ( Thyroid 2018;28:1339–1348)
KimSJ, Lee SWL, JeongSY, PakK, KimK. 2018. Diagnostic performance of technetium-99m methoxy-isobutyl-isonitrile for differentiation of malignant thyroid nodules: a systematic review and meta-analysis. Thyroid, 28:1339–1348.
2.
CampennìA, GiovanellaL, SiracusaM, AlibrandiA, PignataSA, GiovinazzoS, TrimarchiF, RuggeriRM, BaldariS. 2016. (99m)Tc-methoxy-isobutyl-isonitrile scintigraphy is a useful tool for assessing the risk of malignancy in thyroid nodules with indeterminate fine-needle cytology. Thyroid, 26:1101–1109.
3.
GiovanellaL, CampennìA, TregliaG, VerburgFA, TrimboliP, CerianiL, BongiovanniM. 2016. Molecular imaging with (99m)Tc-MIBI and molecular testing for mutations in differentiating benign from malignant follicular neoplasm: a prospective comparison. Eur J Nucl Med Mol Imaging, 43:1018–1026.
4.
BoiF, LaiML, DeiasC, PigaM, SerraA, UcchedduA, FaaG, MariottiS. 2003. The usefulness of 99mTc-SestaMIBI scan in the diagnostic evaluation of thyroid nodules with oncocytic cytology. Eur J Endocrinol, 149:493–498.
5.
SaggioratoE, AngustiT, RosasR, MartineseM, FinessiM, AreccoF, TrevisiolE, BergeroN, PulighedduB, VolanteM, PodioV, PapottiM, OrlandiF. 2009. 99mTc-MIBI Imaging in the presurgical characterization of thyroid follicular neoplasms: Relationship to multidrug resistance protein expression. J Nucl Med, 50:1785–1793.
6.
GiovanellaL, SurianoS, MaffioliM, CerianiL, SprianoG. 2010. (99m)Tc-sestamibi scanning in thyroid nodules with nondiagnostic cytology. Head Neck, 32:607–611.
